A carregar...
Using heterogeneity of the patient-derived xenograft model to identify the chemoresistant population in ovarian cancer
A cornerstone of preclinical cancer research has been the use of clonal cell lines. However, this resource has underperformed in its ability to effectively identify novel therapeutics and evaluate the heterogeneity in a patient's tumor. The patient-derived xenograft (PDX) model retains the hete...
Na minha lista:
| Publicado no: | Oncotarget |
|---|---|
| Main Authors: | , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Impact Journals LLC
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4226719/ https://ncbi.nlm.nih.gov/pubmed/25209969 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|